Parker Laboratories, Inc.: Drug Recall
Recall #D-1091-2023 · 08/02/2023
Class II: Risk
Recall Details
- Recall Number
- D-1091-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Parker Laboratories, Inc.
- Status
- Terminated
- Date Initiated
- 08/02/2023
- Location
- Fairfield, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8
Reason for Recall
CGMP Deviations
Product Description
Helix Tri-Active Therapy Cream (Camphor 3.2%, Menthol 7.4%, Methyl salicylate 12.5%), packaged in a) 3 fl. oz. roll-on (NDC 30775-052-03) and b) 4 fl. oz. tube (NDC 30775-052-04) Parker Laboratories, Inc. 286 Eldridge Road, Fairfield, NJ 07004
Distribution Pattern
Nationwide within the United States, Singapore, Korea and Hong Kong
Other Recalls by Parker Laboratories, Inc.
- Class II: Risk 08/02/2023
- Class II: Risk 08/02/2023
- Class II: Risk 08/02/2023
- Class II: Risk 08/02/2023
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.